Nanobiotix Total Assets (Quarterly) Trends

Nanobiotix SA (NBTX)

7.32 +0.06 (+0.83%) USD | NASDAQ | May 17, 16:00

7.32 0.00 (0.00%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	103.79M
June 30, 2023	43.91M
June 30, 2023	43.91M
December 31, 2022	64.10M
June 30, 2022	84.22M
June 30, 2022	84.22M
December 31, 2021	115.22M
June 30, 2021	147.46M
June 30, 2021	147.46M
December 31, 2020	164.85M
June 30, 2020	50.35M
June 30, 2020	50.35M
December 31, 2019	62.96M
June 30, 2019	85.62M
June 30, 2019	85.62M
December 31, 2018	52.84M

Date	Value
June 30, 2018	50.73M
June 30, 2018	50.73M
December 31, 2017	68.94M
June 30, 2017	48.48M
June 30, 2017	48.48M
December 31, 2016	32.14M
June 30, 2016	41.21M
June 30, 2016	41.21M
December 31, 2015	28.88M
June 30, 2015	36.70M
June 30, 2015	36.70M
December 31, 2014	45.06M
June 30, 2014	41.30M
June 30, 2014	41.30M
December 31, 2013	10.27M
December 31, 2012	18.55M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

43.91M

Minimum

Jun 2023

164.85M

Maximum

Dec 2020

88.94M

Average

84.22M

Median

Jun 2022

Total Assets (Quarterly) Benchmarks

DBV Technologies SA	145.90M
Cellectis SA	334.27M
PHAXIAM Therapeutics SA (DELISTED)	--
Genfit SA	192.20M
Innate Pharma SA	203.61M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	105.83M
Shareholders Equity (Quarterly)	-2.038M
Debt to Equity Ratio	-24.67
Current Ratio	1.751
Net Debt Paydown Yield	-0.91%